CONCORDANCE STUDY
Early Access Evaluation of the new SOPHiA DDM™ Community Myeloid Solution
Adapted from Dr. Weei-Yuarn Huang’s (Sunnybrook Health Centre, Ontario, Canada) presentation during the webinar “Evaluating Next-Generation Sequencing Solutions for Real-World Clinical Needs in Myeloid Malignancy,” with permission from the author - This concordance study demonstrates the strong analytical performance of the new SOPHiA DDM™ Community Myeloid Solution and its potential to streamline and consolidate myeloid genomic analysis within a single workflow.
About Dr. Weei-Yuarn Huang
Weei-Yuarn Huang is currently the medical director of molecular diagnostics at Sunnybrook Health Science Center in Toronto, Ontario. Under his leadership, the laboratory has become one of largest tumor NGS testing centers in Ontario. He has published more than 50 peer-reviewed manuscripts and served as a member in advisory boards for molecular testing both provincially and nationally.